Vanessa Barth

A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies

Anke Post, Trevor Smart, Judith Krikke-Workel et al. · Neuropsychopharmacology · 2015 · 96 citations · Full text

Treat Depression, Psychiatry, Medicine +10

Synthesis and Evaluation of¹¹C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging

Ming‐Qiang Zheng, Nabeel Nabulsi, Su Kim et al. · Journal of Nuclear Medicine · 2013 · 90 citations · Full text

Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer

Charles H. Mitch, Steven J. Quimby, Concepción Pedregal et al. · Journal of Medicinal Chemistry · 2011 · 82 citations · Full text

Molecular Pharmacology, Receptor Occupancy Tracers, Preclinical Development +15

Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples

Eyassu Chernet, Laura J. Martin, Dominic Li et al. · Life Sciences · 2005 · 76 citations

Neuroimaging Biomarkers, Nk-1 Receptors, Neurophysiological Biomarkers +9

Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer

Vanessa Barth, Eyassu Chernet, Laura J. Martin et al. · Life Sciences · 2006 · 74 citations

Psychoactive Drug, Psychiatry, Addiction +10